You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 51 No. 7, July 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observations
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Taxol Neuropathy

Electrodiagnostic and Sural Nerve Biopsy Findings

Zarife Sahenk, MD; Richard Barohn, MD; Pamela New, MD; Jerry R. Mendell, MD

Arch Neurol. 1994;51(7):726-729.


Abstract

Taxol has recently been approved for the treatment of ovarian cancer that has failed to respond to other chemotherapeutic agents. A predominantly sensory neuropathy has been reported in patients receiving taxol, but corresponding nerve changes have not been described. The patient described herein received taxol at a dose of 275 mg/m2 every 21 days. The sural nerve biopsy performed after 17 courses of taxol (cumulative dose, 6603 mg) showed severe nerve fiber loss, axonal atrophy, and secondary demyelination. Axonal regeneration was absent. The findings are compatible with a cell body disease or a length-dependent, distal neuropathy with failure of axonal regeneration. The findings observed in taxol-induced neuropathy are important to document for comparison with other neoplastic and paraneoplastic neuropathies affecting patients with cancer.



Author Affiliations

From the Department of Neurology, Ohio State University School of Medicine, Columbus (Drs Sahenk and Mendell), and the Department of Medicine, Division of Neurology, University of Texas Health Science Center at San Antonio (Drs Barohn and New). Dr Barohn is now with the Department of Neurology, University of Texas—Southwestern Medical Center, Dallas.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Peripheral Neuropathy Induced by Microtubule-Stabilizing Agents
Lee and Swain
JCO 2006;24:1633-1642.
ABSTRACT | FULL TEXT  

Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil-Based Paclitaxel in Women With Breast Cancer
Gradishar et al.
JCO 2005;23:7794-7803.
ABSTRACT | FULL TEXT  

Calpain inhibition protects against Taxol-induced sensory neuropathy
Wang et al.
Brain 2004;127:671-679.
ABSTRACT | FULL TEXT  

Painful sensory neuropathy: Prospective evaluation using skin biopsy
Periquet et al.
Neurology 1999;53:1641-1641.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.